Business Context and Reporting Period
Company: Ginkgo Bioworks Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 5, 2026
Reporting Period: Second quarter ended June 30, 2026
This filing serves as a notification that the Company has announced its financial results for the second quarter of 2026. The detailed announcement is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being contained within the attached Exhibit 99.1 (Announcement), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the full announcement in Exhibit 99.1 for comparative financial analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing directs stakeholders to various channels for material information, including the Company's website, investor relations portal, and social media accounts (X, Instagram, Threads, LinkedIn).
Guidance and Risks: No specific guidance, outlook, risk factors, or contingencies are detailed in the body of this 8-K filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Announcement) for actual Q2 2026 financial figures (Revenue, Net Income, Cash Flow).
- Verify year-over-year and quarter-over-quarter performance metrics in the full announcement.
- Check the Company's investor relations website and social media channels for any additional commentary or updates referenced in the filing.
- Confirm the status of the Company's emerging growth company election, as the checkmark status is not explicitly defined in the provided text snippet.